logo
OF SPECIAL INTEREST
Oral direct factor Xa inhibitor gets FDA's OK
New drugs and dosage forms
Clinicians adjust to latest ESA recommendations
State funds medication reconciliation project at Virginia hospital
PTCB considers changes to certification, recertification
News Briefs
Dabigatran-induced rash
Pros and cons of dabigatran
Permission granted
Dabigatran etexilate
Rationale and evidence for extended infusion of piperacillin–tazobactam
Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis
Stability of diluted adenosine solutions in polyvinyl chloride infusion bags
Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags
Pharmacy residency and the medical training model
Inaugural address of the President-elect
2011 Report of the Executive Vice President and Chief Executive Officer
Getting it started
2011 Report of the ASHP Treasurer
Professional Policies Approved by the 2011 ASHP House of Delegates
ASHP Board of Directors, 2011–2012
ASHP Honorary Membership
ASHP Award of Excellence